Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 18,740

Document Document Title
WO/2018/011733A1
A method for purifying acetone includes contacting an initial solution with a basic ion-exchange resin at a temperature of 15°C to 30°C, wherein the initial solution comprises acetone and acetone impurities; and removing the acetone im...  
WO/2018/013782A1
Disclosed is a f fluorination method comprising providing a fluorinating reagent and a solvent to a reaction mixture; providing a compound having the formula Ar-X to the reaction mixture; wherein, A is a aryl, substituted aryl, heteroary...  
WO/2018/011819A1
The present invention relates to a Fuel Supplement comprising of selected plant oils mixed in given proportions, which when added to fuels like petrol and diesel can reduce harmful emissions during combustion of fuel. It can significantl...  
WO/2018/007175A1
Compounds of formula (I); a process for preparation of compounds of formula (I); precursor compounds of formula (II); a process for preparation of precursor compounds of formula (II); compounds of formula (III); a process for the prepara...  
WO/2018/005732A1
Provided herein are curcumin analogues that are able to interact with amyloid beta (Aβ) and to attenuate the copper-induced crosslinking of Aβ. Also provided herein are methods of using the compounds as imaging agents of amyloid beta a...  
WO/2018/001353A1
Provided is a method for preparing apremilast of formula I. Method one: (S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethylamin e N-acetyl-L-leucine salt of formula II is reacted with 3-acetylaminophthalic anhydride of formula III i...  
WO/2017/221847A1
The invention is an iridium compound useful as a material compound for producing a cyclometalated iridium complex, and is an iridium compound represented by general formula (1). The invention is useful particularly as a material compound...  
WO/2017/220051A2
Disclosed are a benserazide hydrochloride pharmaceutical composition and a medical use thereof for lowering blood sugar. The benserazide hydrochloride pharmaceutical composition contains benserazide hydrochloride and a natural product co...  
WO/2017/214873A1
Provided is a method for separating and purifying butanol, acetone and ethanol or purifying butanol by fermentation coupling, comprising the following steps: 1) fermenting using an acetone and butanol-producing bacteria to obtain butanol...  
WO/2017/218219A1
A series of novel bis(hydroxymethyl) alkanoate derivatives of curcuminoids were designed, and synthesized, which show anticancer activity, and in particular to breast cancer, colon cancer, and prostate cancer.  
WO/2017/211129A1
A method for manufacturing an ephedrine or pseudoephedrine intermediate, comprising: using 2-chloropropionyl chloride and benzene as starting raw materials and performing a Friedel-Crafts reaction using a Lewis acid catalyst to generate ...  
WO/2017/207707A1
The present invention relates to the field of organic synthesis and more specifically it concerns a novel compound of formula (I) which could be used as a novel intermediate in the process for the preparation of compound of formula (III).  
WO/2017/193288A1
A series of novel linked indolyl phosphine ligands for transition metals, the synthesis thereof and their use in catalytic coupling reactions are provided. The ligands provide improvements of trasition-metal-catalyzed reactions, includin...  
WO/2017/195835A1
One purpose of the invention is to provide a technique for modifying polyphenols to suppress the occurrence of precipitation and turbidity in water without separate addition of food additives or conducting enzyme treatment. Modified poly...  
WO/2017/191521A1
Photo-thermal catalysts and methods of use are described. The photo-thermal catalyst can include a photo-active metal oxide and, optionally, a plasm on resonance material. The photo- thermal catalyst has a temperature of 150 °C to 400 ...  
WO/2017/191332A3
A process of forming compounds of formula (I) comprising the steps of addition of an amino compound H2NR to a compound of formula (II) followed by cyclization, isomerization and hydrolysis.  
WO/2017/191795A1
The present invention is a rare-earth complex polymer including a trivalent rare-earth ion and a phosphine oxide bidentate ligand. In the present invention, a single phosphine oxide bidentate ligand is coordinated with two rare-earth ion...  
WO/2017/186846A1
The present invention refers to aryl beta diketones of the formula (I) wherein Y, R1, R2 and R3 have the same meaning as given in the description. The invention further refers to fragrance compositions and fragranced articles comprising ...  
WO/2017/183539A1
[Problem] To provide a compound that can be used on an industrial scale. [Solution] A compound represented by general formula (4) or a base adduct thereof. (In the formula, R3 and R4 independently represent a hydrogen atom or the like.)  
WO/2017/184752A1
The present disclosure provides compounds of the formula (I), (II), (III), wherein the variables are as defined herein for use in the treatment of fungal infections. In some embodiments, the fungal infection is an infection of Cryptococc...  
WO/2017/177531A1
Disclosed is a method for preparing 9-fluorenone from fluorene. 9-fluorenone is prepared using fluorene as a raw material, an alkali as a catalyst, an organic solvent containing an aromatic ring and water as a solvent, and a crown ether ...  
WO/2017/170934A1
The present invention pertains to an acetylacetone derivative which is useful in trapping metal elements by complex formation, and a simple and highly versatile synthesis method therefor. More specifically, the present invention pertains...  
WO/2017/172617A3
This present disclosure relates to processes and apparatuses for use of a single dividing wall distillation column for phenol fractionation. More specifically, the present disclosure relates to processes and apparatuses for phenol fracti...  
WO/2017/162511A1
The present invention relates to a process for the purification of curcumin comprising provision of a curcuminoid composition, contacting said curcuminoid composition with basic amino acid or amino acid ester in order to form an amino ac...  
WO/2017/165822A1
A compound, or a stereoisomer, pharmaceutically acceptable salt, or ester thereof, according to formula (III) or according to Table A, a pharmaceutical composition comprising said compound and at least one pharmaceutically acceptable add...  
WO/2017/165822A8
A compound, or a stereoisomer, pharmaceutically acceptable salt, or ester thereof, according to formula (III) or according to Table A, a pharmaceutical composition comprising said compound and at least one pharmaceutically acceptable add...  
WO/2017/165170A1
In some aspects, the present disclosure provides compounds of the formula: wherein the variables are as defined herein. In some embodiments, the present disclosure provides macrocylic compounds and oligomers thereof of formula I. As desc...  
WO/2017/157932A1
The invention relates to a new and efficient process for the preparation of a class of molecules, namely bicyclo[1.1.1]pentanes and derivatives thereof by reaction of [1.1.1]propellane with a variety of reagents under irradiation and/or ...  
WO/2017/155120A1
The present invention addresses the problem of providing a long life catalyst which can be produced simply and inexpensively, which exhibits high activity, and in which metal leakage is suppressed. Provided is a catalyst according to sev...  
WO/2017/148357A1
The present invention relates to a sacubitril intermediate and a preparation method thereof. The sacubitril intermediate can be prepared by subjecting a compound to a deprotection reaction. The intermediate can be used as a raw material ...  
WO/2017/146444A1
The present invention relates to a method for preparing (meth)acrylate group-containing benzophenone for an optical adhesive, comprising the steps of: preparing a raw material composition by mixing a benzophenone-based compound containin...  
WO/2017/147212A1
This disclosure provides compositions of metal-binding fluorinated compounds and associated methods for producing cellular labels for tracking cells by magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomogra...  
WO/2017/143106A1
Provided herein are compositions and methods of treating liver cancer by novel anticancer agents.  
WO/2017/141138A1
Methods of preparing syngas are provided. Blend gas obtained from methane steam reforming can be reacted with CO2 in the presence of a catalyst to provide syngas with a composition ideal for oxo-synthesis.  
WO/2017/140607A1
A method of making spirogalbanone comprising the steps of: (a) subjecting ethynylspirodecanol to a Rupe rearrangement to give a compound of the formula I; (b) converting the compound of (a) to a C1-C4 alkyl acetal; (c) subjecting the ace...  
WO/2017/133675A1
The present invention relates to a method for preparing a high-purity cyclohexenone long-chain alcohol represented by formula I. The compound represented by formula I is prepared by using metal-mediated Barbier reaction. The method of th...  
WO/2017/130156A1
The invention relates to compounds of Formula (I), (II), (III) or (IV), salts thereof, pharmaceutical compositions thereof, as well as methods of treating, curing or preventing HIV in subjects.  
WO/2017/129991A3
There is provided herein a process for the preparation of a compound of formula I (I) or a salt thereof, wherein X1 to X4, Y1 to Y4, Z and n each have meanings provided in the description. There is also provided certain compounds of form...  
WO/2017/130109A1
Disclosed is an improved method of synthesis for Treprostinil comprising condensation reaction of compound (4) with a hydroxyl-protected alkynol (5) to give the condensation product, compound (6). Subjecting compound (6) to oxidation, re...  
WO/2017/125087A1
The present invention relates to a manufacturing method for a high-purity cyclohexenone long-chain alcohol compound represented by formula (I). The manufacturing method for the compound represented by formula (I) adopts a metal-induced B...  
WO/2017/125964A1
The purpose of the present invention is to provide a method for producing a ketene derivative wherein the consumption of a phosphorus compound can be reduced and the discharge of the phosphorus compound into the environment can be also r...  
WO/2017/119515A1
An object of the present invention is to provide a novel ascochlorin derivative which activates adenosine monophosphate-activated protein kinase (AMPK), and is useful in the treatment or prevention of diseases or conditions that involve ...  
WO/2017/116253A1
The present invention relates to the process for production of ketones from secondary alcohols by the use of a hybrid material, formed by the dichlorohydrotris(pyrazol-1-y1)methane iron (II) complex covalently bound to multi-walled carbo...  
WO/2017/114058A1
The present invention discloses a method for preparing an optically active carbonyl compound, comprising the following steps: subjecting an α,β-unsaturated aldehyde or an α,β-unsaturated ketone to an asymmetric hydrogenation catalyze...  
WO/2017/111357A1
Disclosed is a method for recovering phenol and acetone from a bisphenol-A residue decomposition reaction product, the method being capable of improving economic feasibility and efficiency by utilizing a phenol/acetone purification proce...  
WO/2017/106930A1
The present invention describes non-cyclic enaminoketone compounds and their applications relating to absorption electromagnetic energy, in particular UV radiation.  
WO/2017/112702A1
Methods of preparing a fenfluramine active pharmaceutical ingredient are provided. Aspects of the method include (a) hydrolyzing a 2-(3-(trifluoromethyl)phenyl)acetonitrile composition to produce a 2-(3-(trifluoromethyl)phenyl)acetic aci...  
WO/2017/108946A1
Meta and para alkenyl phenols are reacted with hydroxyl benzophenone to produce compounds of the genera formula or which are used as curatives for polymaleimide resins.  
WO/2017/106974A1
Two isoforms of thyroid receptor alpha (THRα1 and THRα2) have been found to be associated with the growth of cancer. Use of inhibitors of THRα1 (Formula I) and/or agonists of THRα2 (Formula II) in the treatment of such cancers is dis...  
WO/2017/104798A1
The objective of a first invention of the present invention is to provide a method that makes it possible to efficiently produce an oxidation reaction product of a hydrocarbon or derivative thereof using the hydrocarbon or derivative the...  

Matches 1 - 50 out of 18,740